Brendan M. O'Malley bought ABEO once, on Apr 25, 2024

Brendan M. O’Malley, J.D., Ph.D., is a Senior Vice President and Chief Legal Officer at Abeona Therapeutics Inc. (ABEO), where he leads the company’s legal and intellectual property strategy and serves as a key member of the executive leadership team.( He joined Abeona in 2019 as Chief IP Counsel and was later elevated to the role of Chief Legal Officer and SVP/General Counsel, bringing extensive experience in biopharmaceutical patent litigation, licensing, and corporate transactions to the gene and cell therapy company.( As a corporate insider, he has reported multiple equity transactions in Abeona shares under SEC Form 4 filings, reflecting his ongoing equity-based compensation and ownership position as a senior officer.(

Before joining Abeona, O’Malley was a partner at the New York patent litigation firm Fitzpatrick, Cella, Harper & Scinto, and continued in that role after its merger with Venable LLP, where he litigated a wide range of biopharmaceutical patent disputes in U.S. district courts, at the Federal Circuit, and before the U.S. Patent and Trademark Office, while also negotiating settlement and license agreements and advising on IP aspects of biotech M&A due diligence.( He holds a J.D. from the Benjamin N. Cardozo School of Law, where he served as a judicial intern to Judge William H. Pauley in the U.S. District Court for the Southern District of New York, a Ph.D. in Molecular Biology & Microbiology from Tufts University School of Medicine, and a B.S. (magna cum laude) from the University of Massachusetts Dartmouth, combining scientific and legal training that underpins his leadership of Abeona’s legal and IP functions.(

Written by Perplexity from public sources.